Discovery of isatin and 1H-Indazol-3-ol (cas 100922-96-1) derivatives as d-amino acid oxidase (DAAO) inhibitors

Add time:08/13/2019    Source:sciencedirect.com

d-Amino acid oxidase (DAAO) is a potential target in the treatment of schizophrenia as its inhibition increases brain d-serine level and thus contributes to NMDA receptor activation. Inhibitors of DAAO were sought testing [6+5] type heterocycles and identified isatin derivatives as micromolar DAAO inhibitors. A pharmacophore and structure-activity relationship analysis of isatins and reported DAAO inhibitors led us to investigate 1H-Indazol-3-ol (cas 100922-96-1) derivatives and nanomolar inhibitors were identified. The series was further characterized by pKa and isothermal titration calorimetry measurements. Representative compounds exhibited beneficial properties in in vitro metabolic stability and PAMPA assays. 6-fluoro-1H-indazol-3-ol (37) significantly increased plasma d-serine level in an in vivo study on mice. These results show that the 1H-indazol-3-ol series represents a novel class of DAAO inhibitors with the potential to develop drug candidates.

We also recommend Trading Suppliers and Manufacturers of 1H-Indazol-3-ol (cas 100922-96-1). Pls Click Website Link as below: cas 100922-96-1 suppliers

Prev:Polysaccharides from lichen Xanthoria parietina: 1,4/1,6-α-d-glucans and a highly branched galactomannan with macrophage stimulating activity via Dectin-2 activation
Next:Idaverine (cas 100927-13-7), an M2- vs. M3-selective muscarinic antagonist, does not prevent motion sickness in cats)